
浏览全部资源
扫码关注微信
421000 湖南 衡阳,南华大学附属南华医院心内科
[ 马小峰,E-mail: godjing1985123@163.com MA Xiaofeng, E-mail: godjing1985123@163.com
收稿:2018-05-11,
修回:2018-08-01,
纸质出版:2018-11-30
移动端阅览
马小峰, 刘欢, 李招兵, 等. miR-23b-3p调控脂蛋白(a)抑制同型半胱氨酸诱导的冠状动脉血管内皮细胞损伤[J]. 第三军医大学学报, 2018,40(22):2074-2080.
Xiaofeng MA, Huan LIU, Zhaobing LI, et al. MiR-23b-3p regulates lipoprotein (a) to protect human coronary vascular endothelial cells against homocysteine-induced injury[J]. Journal of Third Military Medical University, 2018, 40(22): 2074-2080.
马小峰, 刘欢, 李招兵, 等. miR-23b-3p调控脂蛋白(a)抑制同型半胱氨酸诱导的冠状动脉血管内皮细胞损伤[J]. 第三军医大学学报, 2018,40(22):2074-2080. DOI: 10.16016/j.1000-5404.201805205.
Xiaofeng MA, Huan LIU, Zhaobing LI, et al. MiR-23b-3p regulates lipoprotein (a) to protect human coronary vascular endothelial cells against homocysteine-induced injury[J]. Journal of Third Military Medical University, 2018, 40(22): 2074-2080. DOI: 10.16016/j.1000-5404.201805205.
目的
2
探讨miR-23b-3p作为一种高效降低载脂蛋白(a)[apolipoprotein(a),Apo(a)]的内源性miR,对高同型半胱氨酸引起的冠状动脉内皮细胞损伤抑制效果及作用机制。
方法
2
通过生物信息学、miR芯片及基础实验筛选ETS1为靶基因,设计miR-23b-3p mimic/inhibitor。构建pmirGLO- ETS1 3′-UTR质粒分6组转染人冠状动脉内皮细胞(human coronary artery endothelial cells,HCAECs),分别为A组(pmirGLO-ETS1 3′-UTR转染)、B组(miR-23b-3p inhibitor+pmirGLO-ETS1 3′-UTR转染)、C组(miR-23b-3p minics+pmirGLO-ETS13′-UTR转染)、D组(pmirGLO-ETS13′-UTR mut转染)、E组(miR-23b-3p minics+pmirGLO-ETS13′-UTR mut转染)和F组(miR-23b-3p inhibitor +pmirGLO-ETS13′-UTR mut转染),经双荧光素酶报告基因实验验证。HCAECs分为:对照组(无干预)、阴性对照组(miR-23b-3p inhibitor转染)和实验组(miR-23b-3p mimic转染)。3组细胞均置于含1.0 mmol/L同型半胱氨酸(homocysteine
hcy)培养基中培养7 d。检测各组HCAECs存活率、miR-23b-3p和Apo(a) mRNA表达、akt、p-akt和eNOS蛋白表达。
结果
2
双荧光素酶报告基因实验验证miR-23b-3p能够和ETS1 3′-UTR直接结合,可得ETS1是miR-23b-3p直接靶基因。实验组HCAECs存活率(66.22±5.17)%、阴性对照组(42.12±2.35)%和对照组(38.36±2.21)%均显著低于正常HCAECs(
P
<
0.01),实验组HCAECs存活率显著高于阴性对照组和对照组(
P
<
0.01)。转染后,实验组miR-23b-3p mRNA表达显著高于阴性对照组和对照组(
P
<
0.01),实验组Apo(a) mRNA表达显著低于阴性对照组和对照组(
P
<
0.01)。转染后,实验组p-akt表达和eNOS蛋白相对表达显著高于阴性对照组和对照组(
P
<
0.01)。
结论
2
miR-23b-3p能够以ETS1为靶基因,可能通过akt/ eNOS信号通路下调hcy诱导损伤的内皮细胞中Apo(a)表达,从而保护冠状动脉血管内皮细胞。
Objective
2
To explore the role of miR-23b-3p
an endogenous microRNA that efficiently lowers apolipoprotein (a) [Apo (a)] level
in protecting human coronary artery endothelial cells (HCAECs) against homocysteine-induced injury.
Methods
2
Based on the results of bioinformatics analysis
miR chip data and preliminary experimental findings
ETS1 was selected as the target gene for designing miR-23b-3p mimic and inhibitor. The pmirGLO-ETS1 3′-UTR and pmirGLO-ETS1 3′-UTR mut plasmids were constructed and transfected separately into cultured HCAECs along with the miR-23b-3p inhibitor or miR-23b-3p mimics
followed by testing of the double luciferase reporter gene. HCAECs transfected with the miR-23b-3p mimic
miR-23b-3p inhibitor or without transfection were cultured in the presence of 1.0 mmol/L homocysteine for 7 d
and the cell survival rate
expression of miR-23b-3p and Apo (a) mRNA
and expression of akt
p-akt and eNOS proteins were measured.
Results
2
Double luciferase reporter gene assay showed a direct binding of miR-23b-3p to ETS1 3′-UTR
suggesting that ETS1 was the direct target gene of miR-23b-3p. After exposure to homocysteine for 7 d
the survival rate of HCAECs cells transfected with the miR-23b-3p mimic was (66.22±5.17)%
significantly higher than the rate of (42.12±2.35)% in cells transfected with the miR-23b-3p inhibitor and the rate of (38.36±2.21)% in cells without transfection (
P
<
0.01); the cell survival rates in the 3 groups were all significantly lower than that of normal HCAECs (
P
<
0.01). Transfection of HCAECs with the miR-23b-3p mimic significantly up-regulated the expression level of miR-23b-3p mRNA (
P
<
0.01)
lowered the expression level of Apo (a) mRNA (
P
<
0.01)
and increased the expression levels of p-Akt and eNOS proteins (
P
<
0.01).
Conclusion
2
With ETS1 as the target gene
miR-23b-3p decreases the expression level of Apo (a) through the akt/eNOS signaling pathway to protect HCAECs against homocysteine-induced injury.
GRIECO F A, SEBASTIANI G, JUAN-MATEU J, et al . MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p r egulate the expression of proapoptotic BH3-only proteins DP5 and PUMA in human pancreatic β-cells[J ] . Diabetes, 2017, 66(1): 100-112. DOI: 10.2337/db16-0592.
仓沈元.血清同型半胱氨酸、脂蛋白(a)与冠心病的相关性研究[J].国际检验医学杂志, 2017, 38(3): 389-391. DOI: 10.3969/j.issn.1673-4130.2017.03.041.
CANG S Y. Correlation between serum homocysteine, lipoprotein (a) and coronary heart disease[J]. Int J Lab Med, 2017, 38(3): 389-391. DOI: 10.3969/j.issn.1673-4130.2017.03.041.
郑冠群, 盛晓东, 周建龙, 等.高敏C反应蛋白、同型半胱氨酸、白细胞介素2和脂蛋白相关磷脂酶A2与冠心病的相关性研究[J].中国心血管杂志, 2016, 21(3): 50-54. DOI: 10.3969/j.issn.1007-5410.2016.03.010.
ZHENG G Q, SHENG X D, ZHOU J L, et al . Correlation study among high-sensitivity C-reactive protein, homocysteine, interleukin-2, ipoproteinassociated phospholipase A2 and coronary heart disease[J ] . Chin J Cardiovasc Med, 2016, 21 (3): 50-54. DOI: 10.3969/j.issn.1007-5410.2016.03.010.
童海, 雷建军, 莫学靓, 等. miR-23b-3p对肝核因子4的靶基因及效用分析[J].湘南学院学报(医学版), 2015, 2(1): 1-4. DOI: 10.16500/j.cnki.1673-498x.2015.01.001.
TONG H, LEI J J, MO X L, et al .Target gene and effect analysis of miR-23b-3p on hepatocyte nuclear factor 4[J ] . J Xiangnan Univ (Med Sci), 2015, 2(1): 1-4. DOI: 10.16500/j.cnki.1673-498x.2015.01.001.
LIU X, EDINGER R S, KLEMENS C A, et al . A microRNA cluster miR-23-24-27 is upregulated by aldosterone in the distal kidney nephron where it alters sodium transport[J ] . J Cell Physiol, 2017, 232(6): 1306-1317. DOI: 10.1002/jcp.25599.
KAROLAK A M, VAN DER VAART A. Importance of local interactions for the stability of inhibitory helix 1 of Ets-1 in the apo state[J]. Biophys J, 2012, 102(3): 447. DOI: 10.1016/j.bpj.2011.11.2449.
李理, 汤哲, 孙菲, 等.北京地区老年人高同型半胱氨酸血症(Hhcy)与动脉硬化疾病关系的调查研究[J].北京医学, 2016, 38(10): 980-983. DOI: 10.15932/j.0253-9713.2016.10.004.
LI L, TANG Z, SUN F, et al . Investigation of the relationship between Hyperhomocysteinemia(Hhcy) and arteriosclerotic-related diseases of Beijing elderly[J ] . Beijing Med, 2016, 38(10): 980-983. DOI: 10.15932/j.0253-9713.2016.10.004.
林小龙, 何兴兰, 王佐.脂蛋白(a)合成的调节[J].中国生物化学与分子生物学报, 2014, 2(1): 23-29. DOI: 10.13865/j.cnki.cjbmb.2014.01.013.
LI X L, HE X L WANG Z.The regulation of synthesis of lipoprotein (a)[J]. Chin J Biochem Mol Biol, 2014, 2(1): 23-29. DOI: 10.13865/j.cnki.cjbmb.2014.01.013.
段厚全, 王鹤. LDL-C、LP-a与Hcy联合检测在冠心病诊治中的应用[J].海南医学, 2015, 26(10): 1463-1465. DOI: 10.3969/j.issn.1003-6350.2015.10.0521.
DUAN H Q, WANG H.Application of joint detection of serum LDL-C, LP-a and hcy in the diagnosis and treatment of coronary heart disease[J]. Hainan Med, 2015, 26(10): 1463-1465. DOI: 10.3969/j.issn.1003-6350.2015.10.0521.
ZENG J F, ZENG Z L, ZHANG K, et al . miR-23b-3p and miR-125b-5p downregulate apo(a) expression by targeting Ets1 in HepG2 cells[J ] . Cell Biol Int, 2018, 42(3): 313-323.DOI: 10.1002/cbin.10896.
PENÇE S, ÖZBEK E, OZAN T N, et al . Deregulation of seven CpG island-harboring miRNAs in bladder cancer: miR-155 and miR-23b as the most promising oncomiRs[J ] . Cell Mol Biol, 2016, 62(3): 25.
ZHAN L, YAN Y, FU H, et al . Protective role of miR-23b-3p in kainic acid-induced seizure[J ] . Neuroreport, 2016, 27(10): 764-768. DOI: 10.1097/WNR.0000000000000610.
CHO J H, LEE D Y, LEE E S, et al . Increased risk of coronary artery calcification progression in subjects with high baseline Lp(a) levels: The Kangbuk Samsung Health Study[J ] . Int J Cardiol, 2016, 222(9): 233-237. DOI: 10.1016/j.ijcard.2016.07.219.
田永凤, 莫学靓, 雷建军, 等.胆酸通过上调miR-23b-3p抑制载脂蛋白A表达[J].中国动脉硬化杂志, 2016, 24(8): 769-773.
TIAN Y F, MO X L, LEI J J, et al . Bile acid inhibits apolipoprotein A expression in HepG2 cells by up-regulation of miR-23b-3p[J ] . Chin J Arterioscler, 2016, 24(8): 769-773.
何兴兰. H 2 S通过PKCα/FXR及AKT/HNF4α信号途径抑制HepG2细胞apo(a)表达[D ] .衡阳: 南华大学, 2015. [http://cdmd.cnki.com.cn/Article/CDMD-10555-1015422301.htm .
HE X L. H 2 S inhibits apo (a) expression in HepG2 cells through PKC alpha /FXR and AKT/HNF4 alpha signaling pathways[D ] . Hengyang: Nanhua University, 2015.
LI Y, ZALZALA M, JADHAV K, et al . Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, ER stress and lipogenesis and is regulated by HNF4α[J ] . Hepatology, 2016, 63(6): 1860-1874. DOI: 10.1002/hep.28472.
赵岳. miR-23b-3p和miR-125b-5p通过Ets1下调HepG2细胞内apo(a)的研究[D].衡阳: 南华大学, 2014. [http://cdmd.cnki.com.cn/Article/CDMD-10555-1014412092.htm .
ZHAO Y. MiR-23b-3p and miR-125b-5p downregulateapo (a) in HepG2 cellsby Ets1[D]. Hengyang: Nanhua University, 2014.
令狐克刚, 曾玉, 张彦燕, 等.基于p-Akt/eNOS信号的阿司匹林对ox-LDL诱导的人主动脉内皮细胞损伤的保护作用[J].贵阳医学院学报, 2015, 40(8): 785-788.
LINGHU K G, ZENG Y, ZHANG Y Y, et al .Protective effects of p-Akt/eNOS based aspirin on ox-LDL induced human aortic endothelial cells injury[J ] . J Guizhou Med Coll, 2015, 40(8): 785-788.
郭敏, 李世平, 张彤哲, 等.缬沙坦通过PI3K/Akt/eNOS通路保护2型糖尿病大鼠主动脉内皮细胞免受氧化损伤的研究[J].中国医药导报, 2016, 13(19): 18-21.
GUO M, LI S P, ZHANG T Z, et al .Study on the protective effect of Valsartan against oxidative injury of aortic endothelial cells in rats with type 2 diabetes via PI3K/Akt/eNOS pathway[J ] . China Medical Herald, 2016, 13(19): 18-21..
周涛龙.微小RNA-429/455-3p通过VEGFR对血管内皮细胞生物学行为的影响[D].广州: 暨南大学, 2016. [http://www.wanfangdata.com.cn/details/detail.do?_type=degree&id=D01031266 .
ZHOU T L. Effect of micro RNA-429/455-3p on biological behavior of vascular endothelial cells through VEGFR[D]. Guangzhou: Jinan University, 2016.
翟仰魁.红景天苷对体外高糖缺氧环境下大鼠心肌微血管内皮细胞Flk-1/Akt/eNOS信号通路等影响的研究[D].北京: 北京协和医学院, 2013. [http://cdmd.cnki.com.cn/Article/CDMD-10023-1013311337.htm .
ZHAI Y K.Effects of salidroside on Flk-1/Akt/eN OS signaling pathway in rat myocardial microvascular endothelial cells under high glucose and hypoxia in vitro [D ] . Beijing: Peiking Union Medical College, 2013.
REN K, LI T, ZHANG W, et al . miR-199a-3p inhibits cell proliferation and induces apoptosis by targeting YAP1, suppressing Jagged1-Notch signaling in human hepatocellular carcinoma[J ] . J Biomed Sci, 2016, 23(1): 79. DOI: 10.1186/s12929-016-0295-7.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621